Literature DB >> 5473639

Drug-induced lupus erythematosus.

R K Chandra.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5473639     DOI: 10.1007/BF02750912

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


× No keyword cloud information.
  8 in total

1.  CLINICAL MANIFESTATIONS OF SYSTEMIC LUPUS ERYTHEMATOSUS. COMPUTER ANALYSIS OF 520 CASES.

Authors:  E L DUBOIS; D L TUFFANELLI
Journal:  JAMA       Date:  1964-10-12       Impact factor: 56.272

2.  INDUCING AGENTS AND RELATIONSHIP TO OTHER DISEASES.

Authors:  L E SHULMAN
Journal:  Arthritis Rheum       Date:  1963-08

3.  EVIDENCE FOR A PREDISPOSITION TO RHEUMATIC DISEASES IN FAMILIES OF PATIENTS DEVELOPING DRUG-INDUCED SYSTEMIC LUPUS ERYTHEMATOSUS.

Authors:  H L HOLLEY
Journal:  Arthritis Rheum       Date:  1964-12

4.  Dermal chemical response to analogues of dilantin.

Authors:  J C HOUCK
Journal:  J Invest Dermatol       Date:  1963-02       Impact factor: 8.551

Review 5.  Drug-induced lupus syndromes.

Authors:  D Alarcón-Segovia
Journal:  Mayo Clin Proc       Date:  1969-09       Impact factor: 7.616

6.  Clinical and experimental studies on the hydralazine syndrome and its relationship to systemic lupus erythematosus.

Authors:  D Alarcón-Segovia; K G Wakim; J W Worthington; L E Ward
Journal:  Medicine (Baltimore)       Date:  1967-01       Impact factor: 1.889

7.  THE EFFECT OF HYDRALAZINE (APRESOLINE) ON COLLAGEN SYNTHESIS IN CARRAGEENIN GRANULOMAS.

Authors:  E MEILMAN; M URIVETSKY; C RAPOPORT
Journal:  Arthritis Rheum       Date:  1965-02

8.  Isoniazid and wound healing.

Authors:  J W MARTYN; H H CAMPBELL
Journal:  Can Med Assoc J       Date:  1963-02-02       Impact factor: 8.262

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.